- Home
- RILY vs ALEC Comparison
RILY vs ALEC Comparison
Compare RILY & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RILY | ALEC |
|---|---|---|
| Founded | 1973 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 154.9M | 133.2M |
| IPO Year | 2007 | 2019 |
Fundamental Metrics
Financial Performance| Metric | RILY | ALEC |
|---|---|---|
| Price | $4.19 | $1.28 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | 585.3K | ★ 1.6M |
| Earning Date | 01-13-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $567,999,000.00 | $69,048,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $160.66 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 12.26 |
| 52 Week Low | $2.67 | $0.87 |
| 52 Week High | $7.90 | $3.40 |
Technical Indicators
Market Signals| Indicator | RILY | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 43.67 | 42.34 |
| Support Level | $3.73 | $1.09 |
| Resistance Level | $4.27 | $1.39 |
| Average True Range (ATR) | 0.37 | 0.10 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 43.93 | 63.33 |
Price Performance
Historical ComparisonAbout RILY B. Riley Financial Inc.
B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.